Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

3 in 1, 3 in 1- occ maybe a hindrance rather than a help? Yes, the antibacterial component is mostly what I am thinking of. The average COVID pt does NOT get antibiotics now, unless odd chest x ray or CT or positive sputum or very elevated procalcitonin. Otherwise they are treated with an antiviral and an anti-inflammatory drug- not antibiotics. Do some go on to develop a bacterial component to their illness? Of course just like anybody very ill, staying a long time in a hospital, on a vent etc etc.

BUT- killing off the gut flora with an antibiotic may have consequences, for one thing. The average clinician wants to think that they can direct his/her therapy and not just shotgun it. Providing quite broad antibiotic coverage is one of the things that B does as part of the package of effects. But how much that 1 part of 3 in 1 will help is not certain at all at this point.

It will be one of the fascinating things to look at in the trial